Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
23 May 2024
Historique:
accepted: 09 05 2024
revised: 01 05 2024
received: 06 05 2023
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 23 5 2024
Statut: aheadofprint

Résumé

The exchange of genes between cells is known to play an important physiological and pathological role in many organisms. We show that circulating tumor DNA (ctDNA) facilitates cell-specific gene transfer between human cancer cells and explain part of the mechanisms behind this phenomenon. As ctDNA migrates into the nucleus, genetic information is transferred. Cell targeting and ctDNA integration require ERVL, SINE or LINE DNA sequences. Chemically manufactured AluSp and MER11C sequences replicated multiple myeloma (MM) ctDNA cell targeting and integration. Additionally, we found that ctDNA may alter the treatment response of MM and pancreatic cancer models. This study shows that retrotransposon DNA sequences promote cancer gene transfer. However, because cell-free DNA has been detected in physiological and other pathological conditions, our findings have a broader impact than just cancer. Furthermore, the discovery that transposon DNA sequences mediate tissue-specific targeting will open up a new avenue for the delivery of genes and therapies.

Identifiants

pubmed: 38783375
pii: 7680631
doi: 10.1093/nar/gkae427
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Georgia Research Alliance Venture Development Award
ID : 1R01CA233945
Organisme : NCI NIH HHS
Pays : United States
Organisme : Dwoskin, and Anthony Rizzo Families Foundations
Organisme : Jaime Erin Follicular Lymphoma Research Consortium
Organisme : Clinical and Translational Science Award Program
ID : UL1TR000454
Organisme : NIH HHS
Pays : United States
Organisme : NCATS NIH HHS
Pays : United States
Organisme : Winship Cancer Institute of Emory University
Organisme : NCI NIH HHS
ID : 2P30CA138292-04
Pays : United States

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.

Auteurs

Munevver Cinar (M)

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Lourdes Martinez-Medina (L)

Kodikaz Therapeutic Solutions, Inc, New York, NY, USA.

Pavan K Puvvula (PK)

Kodikaz Therapeutic Solutions, Inc, New York, NY, USA.

Arsen Arakelyan (A)

Bioinformatics group, Institute of Molecular Biology NAS RA, Yerevan, Armenia.

Badri N Vardarajan (BN)

Kodikaz Therapeutic Solutions, Inc, New York, NY, USA.

Neil Anthony (N)

Integrated Cellular Imaging Core, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Ganji P Nagaraju (GP)

Division of hematology and oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

Dongkyoo Park (D)

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Lei Feng (L)

Kodikaz Therapeutic Solutions, Inc, New York, NY, USA.

Faith Sheff (F)

Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Marina Mosunjac (M)

Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Debra Saxe (D)

Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Steven Flygare (S)

Department of Computational Biology/ Genetics, The University of Utah, Salt Lake City, UT, USA.

Olatunji B Alese (OB)

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Jonathan L Kaufman (JL)

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Sagar Lonial (S)

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Juan M Sarmiento (JM)

Department of Surgery, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Izidore S Lossos (IS)

Department of Medicine, Division of Hematology-Oncology and Molecular and Cellular Pharmacology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.

Paula M Vertino (PM)

Department of Biomedical Genetics and the Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.

Jose A Lopez (JA)

Bloodworks Northwest Research Institute, Division of Hematology, University of Washington School of Medicine, Seattle, WA, USA.

Bassel El-Rayes (B)

Division of hematology and oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

Leon Bernal-Mizrachi (L)

Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Classifications MeSH